Triazoles as NR2B receptor inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9981950
SERIAL NO

15503864

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided here in are compounds of Formula I having the structure: Also provided herein are compositions comprising compounds of Formula I and methods of using compounds of Formula I for the treatment of disorders, diseases or conditions mediated by GluN2B receptors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JANSSEN PHARMACEUTICALS INCTITUSVILLE NJ 08560

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dost, Rita Dresden, DE 14 122
Egerland, Ute Radebeul, DE 30 229
Höfgen, Norbert Ottendorf-Okrilla, DE 8 63
Langen, Barbara Radebeul, DE 14 128
Lankau, Hans-Joachim Weinböhla, DE 19 100
Schindler, Rudolf Dresden, DE 24 300
Ward, Simon Lewes Sussex, GB 23 86

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 29, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 29, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00